Context: Recently, two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson’s disease. Researchers are investigating the use of cells derived from human induced pluripotent stem cells and human embryonic stem cells to treat Parkinson's disease.
Relevance of the Topic: Prelims: Key facts about Parkinson's Disease; Stem cells; Types of Stem Cells.
Parkinson’s Disease
- Parkinson’s disease is a neurodegenerative disease characterised by the progressive loss of neurons that produce dopamine, a neurotransmitter.
- Symptoms: It affects both the motor system and non-motor systems. The symptoms include:
- Motor: Tremors, rigidity, bradykinesia, or slow movement, and postural instability.
- Non-Motor: As the disease progresses, non-motor symptoms like cognitive decline, sleep disturbances, mood disorders often emerge.
- Treatment:
- No cure is known and the treatment aims to mitigate symptoms.
- Cell therapy, specifically replenishing dopamine-producing neurons (dopaminergic) in the brain, could provide a potentially more effective treatment.

What are Stem cells?
- Stem cells are undifferentiated cells with the potential to develop into specialised cell types in the body. They can self-renew which makes them valuable for therapeutic applications.
- Stem cell therapy utilises stem cells to promote the repair, regeneration, or replacement of damaged or diseased tissues within the body.
Types of Stem cells:
- Totipotent: Most versatile, with potential to differentiate into all different cell types of an organism and extraembryonic cells (including placenta and umbilical cord). Only found in fertilised eggs (zygote).
- Pluripotent: Derived from inner cell mass of a blastocyst (an early-stage embryo). Can give rise to all different cell types in the body (except extraembryonic cells). E.g., Embryonic stem cells and induced pluripotent stem cells (genetically reprogrammed to the pluripotent state from adult cells).
- Multipotent: More specialised than pluripotent stem cells and can differentiate into limited range of cell types within a specific tissue or organ. E.g., Hematopoietic stem cells (give rise to various blood cell types), mesenchymal stem cells (can differentiate into bone, cartilage, fat cell etc.)
- Unipotent: Most specialised type of stem cells, can only renew themselves and differentiate into one specific cell type. E.g., Stem cells in skin that can only differentiate into another skin cell.
Clinical trials utilising Stem Cell Therapy to treat Parkinson’s Disease
1. Using induced Pluripotent stem cells:
- Patients received transplantation of dopaminergic progenitors (early-stage stem cells capable of differentiating into dopamine-producing neurons) derived from human induced pluripotent stem cells into both sides of the brain.
- The transplanted cells produced dopamine without overgrowth or forming tumours. No serious adverse events were reported. The researchers observed a decrease in motor symptoms associated with Parkinson’s disease.
2. Using human embryonic stem cells:
- Patients received surgical transplantation of bemdaneprocel (dopaminergic neuron progenitor cell product derived from human embryonic stem cells) on both sides of the brain.
- No severe adverse effects and some improvement in motor function was observed in patients.
Challenges using Stem Cell Therapy
- Difficulty in making stem cells fully function like natural insulin-producing cells.
- Risk of the body rejecting the transplanted cells. Avoiding rejection will require long-term immuno-suppression that could cause infections and cancer.
- Ensuring long-term survival and effectiveness of the transplanted cells.
- Potential ethical concerns with using embryonic stem cells. Regulatory approvals by the authorities needed before becoming available to the broader public.
- High cost and complexity of the therapy for widespread use.














